Literature DB >> 25953723

MicroRNA-429 suppresses cell proliferation, epithelial-mesenchymal transition, and metastasis by direct targeting of BMI1 and E2F3 in renal cell carcinoma.

Mingning Qiu1, Ziji Liang1, Lieqian Chen1, Guobin Tan1, Kangning Wang1, Lei Liu1, Jianjun Liu2, Hege Chen3.   

Abstract

BACKGROUND: MicroRNA-429 (miR-429), a short noncoding RNA belonging to the miR-200 superfamily, plays a crucial role in tumorigenesis and tumor progression. It also acts as a modulator of epithelial-to-mesenchymal transition, a cell development regulating process that affects tumor development and metastasis. The aim of this study was to investigate the potential role of miR-429 in regulating growth and metastasis of renal cell carcinoma.
METHODS: miR-429 expression was stably up-regulated or down-regulated in the renal cell carcinoma ACHN and A498 cell lines, and cell proliferation and metastasis were assessed.
RESULTS: miR-429 overexpression inhibited cell proliferation, colony formation, migration, and invasion. Suppression of endogenous miR-429 promoted cell growth and metastasis. miR-429 was shown to directly target the 3' untranslated regions of B-cell-specific Moloney murine leukemia virus insertion site 1 (BMI1) and E2F transcription factor 3 (E2F3) transcripts, regulating their expression, as well as that of the downstream epithelial-to-mesenchymal transition markers E-cadherin, N-cadherin, vimentin, p14, and p16.
CONCLUSIONS: These results revealed a tumor suppressive role for miR-429 in renal cell carcinoma through directly targeting BMI1 and E2F3.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  BMI1; E2F3; Renal carcinoma cells; miR-429

Mesh:

Substances:

Year:  2015        PMID: 25953723     DOI: 10.1016/j.urolonc.2015.03.016

Source DB:  PubMed          Journal:  Urol Oncol        ISSN: 1078-1439            Impact factor:   3.498


  15 in total

1.  miRNA-429 Inhibits Astrocytoma Proliferation and Invasion by Targeting BMI1.

Authors:  Gang Peng; Yiwei Liao; Chenfu Shen
Journal:  Pathol Oncol Res       Date:  2016-09-23       Impact factor: 3.201

2.  Exosomal transfer of miR-429 confers chemoresistance in epithelial ovarian cancer.

Authors:  Taoqiong Li; Li Lin; Qin Liu; Wujiang Gao; Lu Chen; Chunli Sha; Qi Chen; Wenlin Xu; Yuefeng Li; Xiaolan Zhu
Journal:  Am J Cancer Res       Date:  2021-05-15       Impact factor: 6.166

3.  microRNA-451 inhibited cell proliferation, migration and invasion through regulation of MIF in renal cell carcinoma.

Authors:  Yan Tang; Wei Wan; Lijuan Wang; Shishun Ji; Juanjuan Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-12-01

4.  Clinical performance of E2Fs 1-3 in kidney clear cell renal cancer, evidence from bioinformatics analysis.

Authors:  Bin Liang; Jianying Zhao; Xuan Wang
Journal:  Genes Cancer       Date:  2017-05

5.  MiR-429 reverses epithelial-mesenchymal transition by restoring E-cadherin expression in bladder cancer.

Authors:  Chia-Lun Wu; Jar-Yi Ho; Sheng-Chieh Chou; Dah-Shyong Yu
Journal:  Oncotarget       Date:  2016-05-03

6.  miR‑215 promotes epithelial to mesenchymal transition and proliferation by regulating LEFTY2 in endometrial cancer.

Authors:  Xiaoxu Gao; Yan Cai; Ruifang An
Journal:  Int J Mol Med       Date:  2018-05-22       Impact factor: 4.101

Review 7.  MiRNAs and E2F3: a complex network of reciprocal regulations in human cancers.

Authors:  Yanping Gao; Bing Feng; Lu Lu; Siqi Han; Xiaoyuan Chu; Longbang Chen; Rui Wang
Journal:  Oncotarget       Date:  2017-04-21

8.  miR-429 Inhibits Differentiation and Promotes Proliferation in Porcine Preadipocytes.

Authors:  Ying Peng; Fen-Fen Chen; Jing Ge; Jia-Yu Zhu; Xin-E Shi; Xiao Li; Tai-Yong Yu; Gui-Yan Chu; Gong-She Yang
Journal:  Int J Mol Sci       Date:  2016-12-07       Impact factor: 5.923

9.  Epithelial-mesenchymal transition-associated microRNA/mRNA signature is linked to metastasis and prognosis in clear-cell renal cell carcinoma.

Authors:  Hana Mlcochova; Tana Machackova; Anja Rabien; Lenka Radova; Pavel Fabian; Robert Iliev; Katerina Slaba; Alexandr Poprach; Ergin Kilic; Michal Stanik; Martina Redova-Lojova; Marek Svoboda; Jan Dolezel; Rostislav Vyzula; Klaus Jung; Ondrej Slaby
Journal:  Sci Rep       Date:  2016-08-23       Impact factor: 4.379

10.  lncRNA PVT1 and its splicing variant function as competing endogenous RNA to regulate clear cell renal cell carcinoma progression.

Authors:  Tao Yang; Hui Zhou; Peijun Liu; Libin Yan; Weimin Yao; Ke Chen; Jin Zeng; Heng Li; Junhui Hu; Hua Xu; Zhangqun Ye
Journal:  Oncotarget       Date:  2017-07-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.